Locations:
Search IconSearch
March 4, 2015/Cancer/News & Insight

Case Comprehensive Cancer Center Leaders Discuss Care Issues (Video)

Cleveland Clinic and partners address treatment, funding, research challenges

city club video

Cleveland Clinic, University Hospitals Case Medical Center and Case Western Reserve University are partners in the Case Comprehensive Cancer Center (CCCC), which integrates cancer treatment, research, clinical trials, prevention, screening and education activities in Northern Ohio. This collaborative pools the expertise and resources of its three member institutions and leverages those to acquire research funding and provide advanced cancer care. It is one of 41 National Cancer Institute-designated comprehensive cancer centers nationwide, and one of only a handful of “matrix” centers composed of multiple, independent partners.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

“We honestly believe that the sum of the parts greatly exceeds one plus one plus one,” says Brian Bolwell, MD, Chairman of Cleveland Clinic’s Taussig Cancer Institute and CCCC Associate Director.

From Science to Cancer Cures Panel Video

From Science to Cancer Cures Panel Video

In this video, Dr. Bolwell and fellow CCCC leaders participate in a recent panel discussion organized by the City Club of Cleveland: “From Science to Cancer Cures: How the Case Comprehensive Cancer Center Makes the City of Cleveland Better.” Topics include cancer research projects underway at CCCC; the state of cancer research funding; population-based research and disparities in cancer incidence and treatment access in Northern Ohio; genetic/genomic screening and predictors of cancer risk; integrative oncology; the importance of translational research, and potential solutions for the escalating cost of cancer care.

Photo credit: ©The City Club of Cleveland

Advertisement

Related Articles

Doctors working on MGUS screening study
March 18, 2024/Cancer/Research
Pilot Study Aims for Early Identification of Multiple Myeloma Precursor Among Black Patients

First-of-its-kind research investigates the viability of standard screening to reduce the burden of late-stage cancer diagnoses

Hematologist at Cleveland Clinic
March 14, 2024/Cancer/Blood Cancers
Advances in Mantle Cell Lymphoma Treatment (Podcast)

Global R&D efforts expanding first-line and relapse therapy options for patients

Physician with patient
March 6, 2024/Cancer/Research
Targeting Uncontrolled Erythrocytosis in Polycythemia Vera with Rusfertide

Study demonstrates ability to reduce patients’ reliance on phlebotomies to stabilize hematocrit levels

Dr. Jagadeesh at Cleveland Clinic
February 28, 2024/Cancer/Blood Cancers
Treating Patient with Systemic T-Cell Lymphoma and Graft-Versus-Host Disease

A case study on the value of access to novel therapies through clinical trials

Doctor measuring patient's waist size
February 26, 2024/Cancer/Research
Impact of Obesity on GVHD & Transplant Outcomes in Hematologic Malignancies

Findings highlight an association between obesity and an increased incidence of moderate-severe disease

Physician with patient
February 21, 2024/Cancer/Research
Strategies for Improving Clinical Trial Equity

Cleveland Clinic Cancer Institute takes multi-faceted approach to increasing clinical trial access 23456

How antibody drug conjugates work
February 13, 2024/Cancer/Research
Real-World Use of Trastuzumab Deruxtecan

Key learnings from DESTINY trials

CQD-4445459-rotz-650×450
February 7, 2024/Cancer
Advances in Bone Marrow Transplant Have Improved Outcomes in Fanconi Anemia

Overall survival in patients treated since 2008 is nearly 20% higher than in earlier patients

Ad